Eric Lefkofsky has made himself billions of dollars as an entrepreneur. From Groupon to Lightbank, you can see his influence all over the place and you can see his mark will be long lasting. It’s only natural that extends this into the world of medicine. His new startup Tempus aims to change so much of what we think about cancer therapy by giving doctors a new way to find personalized solutions. It isn’t the easiest thing to do but it certainly seems like it’s paying off. So far, Tempus is providing the key to making inroads towards personalized cancer therapy.
The work of Eric Lefkofsky has certainly changed a lot of things once taken for granted about cancer. Tempus is giving personalized medicine through the use of Big Data. When you take in data about somebody’s genetics and lifestyle, you can come up with an accurate idea about what will help them and what will deter good outcomes for cancer. That has lead to better results overall for patients who grow through his system. Doctors are relying on it to give them the help they need in fighting against cancer, but it he isn’t finished yet. He wants to make Tempus into something much larger and more powerful than it is today.
Lefkofsky has certainly proven he understands how to create a startup with teeth. We don’t need to look far to realize that this is one of the most successful biotech startups in years. Others are certainly going to copy what was done here for themselves and try to create companies with a similar Big Data approach. It isn’t something everyone can easily see for themselves, but Lefkofsky has started a revolution. If he has his way, we might just turn the tide on cancer and give patients something they haven’t seen before. The answers to our questions lie in patterns we haven’t seen until now. His legacy is still being written but it seems that he’s headed in the right direction. Things are going to go well for Eric Lefkofsky if he manages to keep things going smoothly.